Key Insights

Highlights

Treatment Research

1 treatments under study, led by Flucinolone Acetonide

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

100%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 4 (1)

Trial Status

Unknown1

Clinical Trials (1)

Showing 1 of 1 trials
NCT00720928Phase 4Unknown

Flucinolone Acetonide Implant for Treating Refractory Ocular Behcet's Disease

Showing all 1 trials

Research Network

Common Treatments

  • Flucinolone Acetonide1

Active Sponsors

  • Kyunghee University Medical Center1
  • Seoul National University Hospital1
  • Asan Medical Center1
  • Samsung Medical Center1

Top Investigators

Related Conditions

  • Noninfectious Uveitis1
  • Ocular Behcets Disease1

Activity Timeline